Medicinal product name Methotrexate "Ebewe" 2.5 mg tablets
Pharmaceutical form Tablet
Strength 2.5 mg 
Information from the MAH on shortages Not available
predicted availability date: not notified
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
05-0313-02 KZSN50 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Package leafletPDF 17-08-2023
Summary of product characteristicsPDF 17-08-2023
Risk minimisation measuresIzglītojošie materiāli ārstam Izglītojošie materiāli ārstam
Izglītojošie materiāli farmaceitam Izglītojošie materiāli farmaceitam
Izglītojošie materiāli pacientam Izglītojošie materiāli pacientam
Vēstule veselības aprūpes speciālistam Vēstule veselības aprūpes speciālistam
ATC code L01BA01 Antineoplastic agents
Information for Marketing authorisation holdersView

Medicinal products (6)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jul 7, 2025
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N30
(2,5 mg)
Polypropylene    05-0313-01
 Is available (according to the information provided by wholesalers)
(27 containers)
Permitted to distribute until Jul 7, 2025
Product suspended from the medicinal product register, distribution permitted for a limited time span
Tamro, Magnum Medical N50
(2,5 mg)
Polypropylene 7.29 
KZS*
05-0313-02
 Not available (according to the information provided by wholesalers)
Permitted to distribute until Jul 7, 2025
Product suspended from the medicinal product register, distribution permitted for a limited time span
currently no information on availability from any wholesaler N100
(2,5 mg)
Polypropylene    05-0313-03
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(2,5 mg)
PVC/PVDC/Al blister    05-0313-04 Labelling text Labelling text Jun 30, 2022
Labelling text Labelling text Jun 30, 2022
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N50
(2,5 mg)
PVC/PVDC/Al blister    05-0313-05 Labelling text Labelling text Jun 30, 2022
Labelling text Labelling text Jun 30, 2022
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(2,5 mg)
PVC/PVDC/Al blister    05-0313-06 Labelling text Labelling text Jun 30, 2022
Labelling text Labelling text Jun 30, 2022
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 05-0313
Date of authorisation Aug 1, 2005
Marketing authorisation holder, country Sandoz d.d., Slovenia